NIHR Experimental Cancer Medicine Centre

The Birmingham ECMC aims to improve the feasibility and quality of research in the areas of immunotherapy and gene therapy, translational genetics and biomarkers which is being conducted in many different types of cancer. The centre has established bio-repositories, developed antibody-based assays and conducted various clinical trials.